
North America Disposable Blood Bag Market – Industry Trends and Forecast to 2030
Report ID: MS-876 | Healthcare and Pharma | Last updated: May, 2025 | Formats*:
The disposable blood bag market is the industry that deals in the production, distribution, and sale of disposable bags for the collection, storage, transport, and transfusion of human blood and its components. They are usually produced with biocompatible plastics such as medical-grade PVC for safety and integrity of blood products. They are available in various forms, including single, double, triple, and quadruple bags, each being designed for specialised use in blood banking and transfusion medicine to ensure separation of blood into various components such as plasma, red blood cells, and platelets.
The growth of the market is majorly influenced by the growing number of blood transfusion procedures in the world, an increase in cases of trauma and accidents demanding blood transfusions, and an increase in blood-related disorders. The focus on hygiene and safety in healthcare environments also drives demand for disposable products to reduce the chances of infections.

Disposable Blood Bag Report Highlights
Report Metrics | Details |
---|---|
Forecast period | 2019-2030 |
Base Year Of Estimation | 2024 |
Growth Rate | CAGR of 4.81% |
Forecast Value (2030) | USD 574.77 Billion |
By Product Type | Transfer Bag, Double Blood Bag, Triple Blood Bag, Collection Bag, Triple top and bottom blood bags |
Key Market Players |
|
By Region |
|
Disposable Blood Bag Market Trends
The disposable blood bag market is presently witnessing some major trends. One of the main drivers is the growing rate of road traffic accidents and trauma cases worldwide, which is necessitating a greater demand for blood transfusions. For example, the World Health Organisation estimates that more than one million people are killed every year due to traffic accidents, who in turn may need huge blood transfusions. Likewise, the increased incidence of blood disorders like anaemia, haemophilia, and leukaemia requires frequent blood transfusions, driving the market further.
The other major trend is the increasing number of surgical operations conducted globally, which necessarily raises the demand for blood and blood components. The government and non-governmental initiatives encouraging blood donation are also creating a higher supply of donated blood and, in turn, augmenting the demand for disposable blood bags for collection, storage, and transport.
Disposable Blood Bag Market Leading Players
The key players profiled in the report are Haemonetics Corporation (United States)Innvol Medical India Limited (India), Neomedic International (United States), Teleflex Incorporated (United States), Span Healthcare Private Limited (India), MacoPharma, S.A. (France, Fresenius SE & Co. KGaA (Germany), Poly Medicure Limited (India), Grifols, S.A. (Spain), Terumo Corporation (United States)Growth Accelerators
First, the growing incidence of accidents and trauma worldwide directly increases the demand for blood transfusions, in turn promoting market growth for disposable blood bags used for safe collection and administration. Second, the growth in the incidence of blood-related disorders like anaemia, thalassaemia, and haemophilia creates high demand for repeated transfusions, thus increasing market growth. In addition, the increasing rate of surgeries conducted across the world, such as intricate cardiovascular surgeries and organ transplants, demands large blood supplies, thus raising the usage of disposable blood bags.
Furthermore, increased awareness and efforts towards blood donation from government and non-governmental bodies significantly boost the market. With increasing donations of blood, there is increased demand for secure and dependable solutions for the collection and storage of blood, offered by disposable blood bags.
Disposable Blood Bag Market Segmentation analysis
The North America Disposable Blood Bag is segmented by Type, Application, and Region. By Type, the market is divided into Distributed Transfer Bag, Double Blood Bag, Triple Blood Bag, Collection Bag, Triple top and bottom blood bags . The Application segment categorizes the market based on its usage such as Hospitals, Blood Banks. Geographically, the market is assessed across key Regions like North America (United States, Canada, Mexico), South America (Brazil, Argentina, Chile, Rest of South America), Europe (Germany, France, Italy, United Kingdom, Benelux, Nordics, Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, Southeast Asia, Rest of Asia-Pacific), MEA (Middle East, Africa) and others, each presenting distinct growth opportunities and challenges influenced by the regions.Competitive Landscape
The disposable blood bag market is dominated by a competitive landscape of a fragmented market consisting of both established global players and smaller regional producers. Major players emphasise increasing geographical reach and product offerings through strategic acquisitions, mergers, and partnerships. Design innovation, including increased durability, better safety features, and the incorporation of cutting-edge technologies like RFID for enhanced tracking and management, is a key competitive driver. In addition, the growing focus on green and biocompatible materials is influencing market participants' strategies as they react to environmental issues and regulatory pressures.
Competition is also fuelled by aspects like product quality, price, and the capacity to fulfil the particular requirements of various end-users like hospitals, blood banks, and non-governmental organizations. The increased healthcare infrastructure in emerging nations, especially in the Asia Pacific, is also fuelling competition as local entrants emerge and global companies compete for market share in these high-growth regions.
Challenges In Disposable Blood Bag Market
The disposable blood bag market is confronted by a number of key challenges that are likely to stifle its growth path. Strict regulatory measures and quality controls on medical devices impose high entry barriers, particularly for small producers, since complying requires heavy investment in sophisticated production and testing equipment. Also, fluctuations in raw material costs – especially those of plastic polymers – affect production cost and profitability and render it hard for companies to offer competitive pricing and stable supply chains. Efficient waste management solutions are also challenging the market because disposing of plastic medical waste from blood bags creates environmental issues and regulatory concerns.
The second critical challenge is insufficiencies of proper blood-collecting facilities and blood repositories in the newly industrialising markets, limiting markets' potential there. Uncomfortably low blood donation rates in combination with health fears relating to contamination or contraction of blood-transmitted diseases at the low side of per capita GDP remain additional hurdles hindering markets there. Amidst these impediments, some partial counterbalancing is being derived from sustained future progress in bag technology and growing global health outlays, which are continuing across the developed nations.
Risks & Prospects in Disposable Blood Bag Market
The market for disposable blood bags offers huge opportunities fuelled by the growing incidence of chronic diseases, rising road traffic accidents, and the growing need for safe blood transfusion techniques across the world. The market is also being supported by growing healthcare infrastructure, especially in emerging markets, and the growing number of surgical interventions involving blood transfusions. Major players are investing in innovation, strategic alliances, and geographic penetration to gain greater market share.
Geographically, North America and Europe are leading the market because of their superior healthcare systems, high per capita spending on healthcare, and well-entrenched blood banking networks. But the Asia-Pacific market is gaining pace as the fastest-growing market, driven by its huge population, rising investments in healthcare, and enhanced awareness regarding the donation of blood and safety standards. These countries are major contributors to this growth and include Japan as the leader in technology adoption and India, which has the highest growth rate due to initiatives by the government and increasing medical facilities.
Key Target Audience
, Other organizations and NGOs are instrumental in the market by hosting blood donation camps and offering blood transfusion services, particularly in the remote areas. The rising incidence of disorders related to blood, including haemophilia and anaemia, which involve constant transfusions, also fuels the demand for disposable blood bags. Besides, international efforts toward increasing awareness about blood donation and enhancing healthcare facilities add to the increasing demand for safe and efficient blood collection and storage technologies.
The main target market for the disposable blood bag market is hospitals, blood banks, and non-governmental institutions (NGOs). The largest consumers are hospitals, which hold about 45% of the market share in 2022 owing to the rising number of surgeries and the spread of chronic diseases that require blood transfusions. Blood banks are also prominent end-users, tasked with gathering, processing, and storing blood, and they are growing as a result of increased voluntary donation of blood and the demand for effective blood storage solutions.
,
Merger and acquisition
The market for disposable blood bags has witnessed significant merger and acquisition activity over the past few years, demonstrating a push toward innovation and increased market presence. In January 2021, Haemonetics Corporation acquired Cardiva Medical Inc. to diversify its hospital products in the interventional cardiology space, including disposable blood bags. This action was preceded by Haemonetics' takeover of Attune Medical in April 2024 for $160 million to augment its strength in temperature control devices applicable in blood transfusion procedures. Grifols, in its turn, grew its plasma collection network by purchasing seven U.S. plasma donation facilities from Kedrion for $55.2 million in April 2021 to gain access to about 240,000 litres of plasma each year.
Aside from these purchases, firms are turning their attention to strategic partnerships and product development to consolidate their market presence. In August 2022, Haemonetics collaborated with Epic Systems to incorporate its SafeTrace Tx blood bank information system into Epic's international network of hospitals with the aim of streamlining blood management procedures. Fresenius Kabi made a statement in August 2023 about advancements in the creation of DEHP-free blood bag systems as part of increasing environmental and safety requirements. These advancements reflect a larger industry trend toward increasing product safety, regulatory compliance, and operational efficiency through strategic alliances and technological innovation.
>Analyst Comment
The disposable blood bag market around the world is experiencing steady growth due to growing demand for safe transfusion and blood collection, an upsurge in road accidents, trauma, and rising cases of chronic diseases that need more frequent blood transfusions. In 2025, the market size will be estimated between USD 283.6 million and USD 406.2 million, based on the source, with growth projections showing a compound annual growth rate (CAGR). The increased number of surgical interventions across the globe, combined with the growing healthcare infrastructure – particularly in developing economies – continues to fuel market growth.
- 1.1 Report description
- 1.2 Key market segments
- 1.3 Key benefits to the stakeholders
2: Executive Summary
- 2.1 Disposable Blood Bag- Snapshot
- 2.2 Disposable Blood Bag- Segment Snapshot
- 2.3 Disposable Blood Bag- Competitive Landscape Snapshot
3: Market Overview
- 3.1 Market definition and scope
- 3.2 Key findings
- 3.2.1 Top impacting factors
- 3.2.2 Top investment pockets
- 3.3 Porter’s five forces analysis
- 3.3.1 Low bargaining power of suppliers
- 3.3.2 Low threat of new entrants
- 3.3.3 Low threat of substitutes
- 3.3.4 Low intensity of rivalry
- 3.3.5 Low bargaining power of buyers
- 3.4 Market dynamics
- 3.4.1 Drivers
- 3.4.2 Restraints
- 3.4.3 Opportunities
4: Disposable Blood Bag Market by Type
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Collection Bag
- 4.2.1 Key market trends, factors driving growth, and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
- 4.3 Transfer Bag
- 4.3.1 Key market trends, factors driving growth, and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
- 4.4 Double Blood Bag
- 4.4.1 Key market trends, factors driving growth, and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market share analysis by country
- 4.5 Triple Blood Bag
- 4.5.1 Key market trends, factors driving growth, and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market share analysis by country
- 4.6 Triple top and bottom blood bags
- 4.6.1 Key market trends, factors driving growth, and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market share analysis by country
5: Disposable Blood Bag Market by Application / by End Use
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Hospitals
- 5.2.1 Key market trends, factors driving growth, and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
- 5.3 Blood Banks
- 5.3.1 Key market trends, factors driving growth, and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
6: Disposable Blood Bag Market by Region
- 6.1 Overview
- 6.1.1 Market size and forecast By Region
- 6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 Market size and forecast, by Type
- 6.2.3 Market size and forecast, by Application
- 6.2.4 Market size and forecast, by country
- 6.2.4.1 United States
- 6.2.4.1.1 Key market trends, factors driving growth, and opportunities
- 6.2.4.1.2 Market size and forecast, by Type
- 6.2.4.1.3 Market size and forecast, by Application
- 6.2.4.2 Canada
- 6.2.4.2.1 Key market trends, factors driving growth, and opportunities
- 6.2.4.2.2 Market size and forecast, by Type
- 6.2.4.2.3 Market size and forecast, by Application
- 6.2.4.3 Mexico
- 6.2.4.3.1 Key market trends, factors driving growth, and opportunities
- 6.2.4.3.2 Market size and forecast, by Type
- 6.2.4.3.3 Market size and forecast, by Application
- 6.2.4.1 United States
- 6.3 South America
- 6.3.1 Key trends and opportunities
- 6.3.2 Market size and forecast, by Type
- 6.3.3 Market size and forecast, by Application
- 6.3.4 Market size and forecast, by country
- 6.3.4.1 Brazil
- 6.3.4.1.1 Key market trends, factors driving growth, and opportunities
- 6.3.4.1.2 Market size and forecast, by Type
- 6.3.4.1.3 Market size and forecast, by Application
- 6.3.4.2 Argentina
- 6.3.4.2.1 Key market trends, factors driving growth, and opportunities
- 6.3.4.2.2 Market size and forecast, by Type
- 6.3.4.2.3 Market size and forecast, by Application
- 6.3.4.3 Chile
- 6.3.4.3.1 Key market trends, factors driving growth, and opportunities
- 6.3.4.3.2 Market size and forecast, by Type
- 6.3.4.3.3 Market size and forecast, by Application
- 6.3.4.4 Rest of South America
- 6.3.4.4.1 Key market trends, factors driving growth, and opportunities
- 6.3.4.4.2 Market size and forecast, by Type
- 6.3.4.4.3 Market size and forecast, by Application
- 6.3.4.1 Brazil
- 6.4 Europe
- 6.4.1 Key trends and opportunities
- 6.4.2 Market size and forecast, by Type
- 6.4.3 Market size and forecast, by Application
- 6.4.4 Market size and forecast, by country
- 6.4.4.1 Germany
- 6.4.4.1.1 Key market trends, factors driving growth, and opportunities
- 6.4.4.1.2 Market size and forecast, by Type
- 6.4.4.1.3 Market size and forecast, by Application
- 6.4.4.2 France
- 6.4.4.2.1 Key market trends, factors driving growth, and opportunities
- 6.4.4.2.2 Market size and forecast, by Type
- 6.4.4.2.3 Market size and forecast, by Application
- 6.4.4.3 Italy
- 6.4.4.3.1 Key market trends, factors driving growth, and opportunities
- 6.4.4.3.2 Market size and forecast, by Type
- 6.4.4.3.3 Market size and forecast, by Application
- 6.4.4.4 United Kingdom
- 6.4.4.4.1 Key market trends, factors driving growth, and opportunities
- 6.4.4.4.2 Market size and forecast, by Type
- 6.4.4.4.3 Market size and forecast, by Application
- 6.4.4.5 Benelux
- 6.4.4.5.1 Key market trends, factors driving growth, and opportunities
- 6.4.4.5.2 Market size and forecast, by Type
- 6.4.4.5.3 Market size and forecast, by Application
- 6.4.4.6 Nordics
- 6.4.4.6.1 Key market trends, factors driving growth, and opportunities
- 6.4.4.6.2 Market size and forecast, by Type
- 6.4.4.6.3 Market size and forecast, by Application
- 6.4.4.7 Rest of Europe
- 6.4.4.7.1 Key market trends, factors driving growth, and opportunities
- 6.4.4.7.2 Market size and forecast, by Type
- 6.4.4.7.3 Market size and forecast, by Application
- 6.4.4.1 Germany
- 6.5 Asia Pacific
- 6.5.1 Key trends and opportunities
- 6.5.2 Market size and forecast, by Type
- 6.5.3 Market size and forecast, by Application
- 6.5.4 Market size and forecast, by country
- 6.5.4.1 China
- 6.5.4.1.1 Key market trends, factors driving growth, and opportunities
- 6.5.4.1.2 Market size and forecast, by Type
- 6.5.4.1.3 Market size and forecast, by Application
- 6.5.4.2 Japan
- 6.5.4.2.1 Key market trends, factors driving growth, and opportunities
- 6.5.4.2.2 Market size and forecast, by Type
- 6.5.4.2.3 Market size and forecast, by Application
- 6.5.4.3 India
- 6.5.4.3.1 Key market trends, factors driving growth, and opportunities
- 6.5.4.3.2 Market size and forecast, by Type
- 6.5.4.3.3 Market size and forecast, by Application
- 6.5.4.4 South Korea
- 6.5.4.4.1 Key market trends, factors driving growth, and opportunities
- 6.5.4.4.2 Market size and forecast, by Type
- 6.5.4.4.3 Market size and forecast, by Application
- 6.5.4.5 Australia
- 6.5.4.5.1 Key market trends, factors driving growth, and opportunities
- 6.5.4.5.2 Market size and forecast, by Type
- 6.5.4.5.3 Market size and forecast, by Application
- 6.5.4.6 Southeast Asia
- 6.5.4.6.1 Key market trends, factors driving growth, and opportunities
- 6.5.4.6.2 Market size and forecast, by Type
- 6.5.4.6.3 Market size and forecast, by Application
- 6.5.4.7 Rest of Asia-Pacific
- 6.5.4.7.1 Key market trends, factors driving growth, and opportunities
- 6.5.4.7.2 Market size and forecast, by Type
- 6.5.4.7.3 Market size and forecast, by Application
- 6.5.4.1 China
- 6.6 MEA
- 6.6.1 Key trends and opportunities
- 6.6.2 Market size and forecast, by Type
- 6.6.3 Market size and forecast, by Application
- 6.6.4 Market size and forecast, by country
- 6.6.4.1 Middle East
- 6.6.4.1.1 Key market trends, factors driving growth, and opportunities
- 6.6.4.1.2 Market size and forecast, by Type
- 6.6.4.1.3 Market size and forecast, by Application
- 6.6.4.2 Africa
- 6.6.4.2.1 Key market trends, factors driving growth, and opportunities
- 6.6.4.2.2 Market size and forecast, by Type
- 6.6.4.2.3 Market size and forecast, by Application
- 6.6.4.1 Middle East
- 7.1 Overview
- 7.2 Key Winning Strategies
- 7.3 Top 10 Players: Product Mapping
- 7.4 Competitive Analysis Dashboard
- 7.5 Market Competition Heatmap
- 7.6 Leading Player Positions, 2022
8: Company Profiles
- 8.1 Fresenius SE & Co. KGaA (Germany)
- 8.1.1 Company Overview
- 8.1.2 Key Executives
- 8.1.3 Company snapshot
- 8.1.4 Active Business Divisions
- 8.1.5 Product portfolio
- 8.1.6 Business performance
- 8.1.7 Major Strategic Initiatives and Developments
- 8.2 Grifols
- 8.2.1 Company Overview
- 8.2.2 Key Executives
- 8.2.3 Company snapshot
- 8.2.4 Active Business Divisions
- 8.2.5 Product portfolio
- 8.2.6 Business performance
- 8.2.7 Major Strategic Initiatives and Developments
- 8.3 S.A. (Spain)
- 8.3.1 Company Overview
- 8.3.2 Key Executives
- 8.3.3 Company snapshot
- 8.3.4 Active Business Divisions
- 8.3.5 Product portfolio
- 8.3.6 Business performance
- 8.3.7 Major Strategic Initiatives and Developments
- 8.4 Haemonetics Corporation (United States)Innvol Medical India Limited (India)
- 8.4.1 Company Overview
- 8.4.2 Key Executives
- 8.4.3 Company snapshot
- 8.4.4 Active Business Divisions
- 8.4.5 Product portfolio
- 8.4.6 Business performance
- 8.4.7 Major Strategic Initiatives and Developments
- 8.5 MacoPharma
- 8.5.1 Company Overview
- 8.5.2 Key Executives
- 8.5.3 Company snapshot
- 8.5.4 Active Business Divisions
- 8.5.5 Product portfolio
- 8.5.6 Business performance
- 8.5.7 Major Strategic Initiatives and Developments
- 8.6 S.A. (France
- 8.6.1 Company Overview
- 8.6.2 Key Executives
- 8.6.3 Company snapshot
- 8.6.4 Active Business Divisions
- 8.6.5 Product portfolio
- 8.6.6 Business performance
- 8.6.7 Major Strategic Initiatives and Developments
- 8.7 Neomedic International (United States)
- 8.7.1 Company Overview
- 8.7.2 Key Executives
- 8.7.3 Company snapshot
- 8.7.4 Active Business Divisions
- 8.7.5 Product portfolio
- 8.7.6 Business performance
- 8.7.7 Major Strategic Initiatives and Developments
- 8.8 Poly Medicure Limited (India)
- 8.8.1 Company Overview
- 8.8.2 Key Executives
- 8.8.3 Company snapshot
- 8.8.4 Active Business Divisions
- 8.8.5 Product portfolio
- 8.8.6 Business performance
- 8.8.7 Major Strategic Initiatives and Developments
- 8.9 Span Healthcare Private Limited (India)
- 8.9.1 Company Overview
- 8.9.2 Key Executives
- 8.9.3 Company snapshot
- 8.9.4 Active Business Divisions
- 8.9.5 Product portfolio
- 8.9.6 Business performance
- 8.9.7 Major Strategic Initiatives and Developments
- 8.10 Teleflex Incorporated (United States)
- 8.10.1 Company Overview
- 8.10.2 Key Executives
- 8.10.3 Company snapshot
- 8.10.4 Active Business Divisions
- 8.10.5 Product portfolio
- 8.10.6 Business performance
- 8.10.7 Major Strategic Initiatives and Developments
- 8.11 Terumo Corporation (United States)
- 8.11.1 Company Overview
- 8.11.2 Key Executives
- 8.11.3 Company snapshot
- 8.11.4 Active Business Divisions
- 8.11.5 Product portfolio
- 8.11.6 Business performance
- 8.11.7 Major Strategic Initiatives and Developments
9: Analyst Perspective and Conclusion
- 9.1 Concluding Recommendations and Analysis
- 9.2 Strategies for Market Potential
Scope of Report
Aspects | Details |
---|---|
By Type |
|
By Application |
|
Report Licenses
Our Team


Frequently Asked Questions (FAQ):
What is the estimated market size of Disposable Blood Bag in 2030?
+
-
Which type of Disposable Blood Bag is widely popular?
+
-
What is the growth rate of Disposable Blood Bag Market?
+
-
What are the latest trends influencing the Disposable Blood Bag Market?
+
-
Who are the key players in the Disposable Blood Bag Market?
+
-
How is the Disposable Blood Bag } industry progressing in scaling its end-use implementations?
+
-
What product types are analyzed in the Disposable Blood Bag Market Study?
+
-
What geographic breakdown is available in North America Disposable Blood Bag Market Study?
+
-
Which region holds the second position by market share in the Disposable Blood Bag market?
+
-
How are the key players in the Disposable Blood Bag market targeting growth in the future?
+
-
First, the growing incidence of accidents and trauma worldwide directly increases the demand for blood transfusions, in turn promoting market growth for disposable blood bags used for safe collection and administration. Second, the growth in the incidence of blood-related disorders like anaemia, thalassaemia, and haemophilia creates high demand for repeated transfusions, thus increasing market growth. In addition, the increasing rate of surgeries conducted across the world, such as intricate cardiovascular surgeries and organ transplants, demands large blood supplies, thus raising the usage of disposable blood bags.
,
, Furthermore, increased awareness and efforts towards blood donation from government and non-governmental bodies significantly boost the market. With increasing donations of blood, there is increased demand for secure and dependable solutions for the collection and storage of blood, offered by disposable blood bags.